1 to 3 of 3 Part-Time Biotechnology Jobs in England

west of London, and with offices in Germany and Switzerland we are proud to be the analytical service provider of choice for pharmaceutical and biotech companies throughout the world. As Numerus continues to grow, we are actively looking to expand our team in Wokingham with a permanent position on a more »

Your new company Hays Life Sciences have been exclusively retained by a VC backed biotech that has already raised tens of millions of pounds of funding and is using its novel platform technology to develop innovative medicines for areas of unmet need, allowing you to have a significant impact on … or a similar Life Sciences discipline, or equivalent experience A strong track record in small molecule drug metabolism, bioanalysis, pharmacokinetics gained in a Pharma, Biotech or CRO environment and familiarity with principles of PKPD modelling, eg using Phoenix or WinNonLin Experience working on diverse drug discovery & development projects, delivering compounds … and statistics positions available. Keywords: DMPK, PKPD, modelling, protein, degradation, Lead, Director, VP, Manager, PK, ADME, Tox, in-vitro, in-vivo, IND, drug, discovery, biotech, pharma, R&D, research, preclinical more »

Your new company You will be joining a breakthrough VC backed biotech who have recently raised a multi-million pound Seed funding round.They are pioneering novel treatments in the field of cancer immunoprevention and are currently developing a lead mRNA vaccine.As they go into the next stage of their growth … role should have an extensive track record/background in vaccinology, with a specialism in mRNA therapeutics and/or vaccines, gained from the biotech/pharma industry Strong knowledge of immunotherapy, ideally applied to oncology Track record of taking programmes through from discovery to IND, with a preference for … RNA therapeutics/vaccines Detailed understanding of current trends and technologies in the RNA space Ability to mentor/support early biotech founders A good understanding of aspects affecting programme prioritisation, eg commercial practicalities and regulatory hurdles faced when gaining approval for a new therapeutic What you'll get in more »